New SFB: 1243 Cancer Evolution
Genetic and Epigenetic Evolution of Hematopoietic Neoplasms
01.12.2015
The goal of this research initiative is to combine clinical oncology, basic research and computational biology to understand how cancer evolves, concentrating on genetic and epigenetic variation that is shaped by mutation and selection during the progression of cancer.
The SFB 1243, chaired by Prof. Heinrich Leonhardt, is composed of research groups from the LMU, TUM and Helmholtz Zentrum in clinical medicine, computational science and biology. The initial funding period begins as of January 1, 2016, and will continue for four years.